Xiao Mei Wu

Gründer bei Tianjin Haifeng Yinhua Investment Management LP

Finance

Profil

Xiao Mei Wu is a founding partner of Tianjin Haifeng Yinhua Investment Management LP, which is founded in 2008.
She is currently a director at Cerevast Medical, Inc.

Aktive Positionen von Xiao Mei Wu

Unternehmen	Position	Beginn
Tianjin Haifeng Yinhua Investment Management LP Tianjin Haifeng Yinhua Investment Management LP Investment ManagersFinance Tianjin Haifeng Yinhua Investment Management LP (Tianjin Haifeng Yinhua Investment Management) is an independent private equity firm founded in 2011. The firm is headquartered in Beijing, China.	Gründer	01.01.2008
Cerevast Medical, Inc. Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA.	Direktor/Vorstandsmitglied	-

Alle aktiven Positionen von Xiao Mei Wu

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Xiao Mei Wu im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Tianjin Haifeng Yinhua Investment Management LP Tianjin Haifeng Yinhua Investment Management LP Investment ManagersFinance Tianjin Haifeng Yinhua Investment Management LP (Tianjin Haifeng Yinhua Investment Management) is an independent private equity firm founded in 2011. The firm is headquartered in Beijing, China.	Finance
Cerevast Medical, Inc. Cerevast Medical, Inc. Investment ManagersFinance Cerevast Neurorehab, Inc. operates as neuroscience medical device technology company. It develops a therapy for the treatment of acute ischemic stroke. The firm offers ClotBust-ER, an operator independent device, which helps in administering ultrasound energy for sonothrombolysis therapy. The company was founded in 2009 and is headquartered in Redmond, WA.	Finance